CS
CTIC

Candriam SCA’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Candriam SCA’s Portfolio CTIC Stock Details CTIC Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$928K Buy
2022
Q4 		$541K Buy
2016
Q1 		– Sell
2015
Q4 		$1.86M Hold
2015
Q3 		$2.21M Buy
2015
Q2 		$2.82M Hold
2015
Q1 		$2.62M Buy
2014
Q4 		$2.65M Buy